17,491 resources
Start Prev Rows 17200 - 17400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.229 | Influenza Vaccine CN_HD_HCPCS | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.230 | Influenza Vaccine CN_HD_CVX | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.231 | Influenza Vaccine CN_HD_CPT | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.368 | Ischemic Vascular Disease (IVD)_ICD10 | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.195 | Lipid Panel_Event_HCPCS | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.197 | Lipid Panel_Event_CPT | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.517 | Lupus_Clinical_Condition_ICD10 | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.550 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.552 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.371 | Muscular Pain and Disease_ICD10 | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.472 | OGTT_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.473 | OGTT_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.386 | Obesity_Condition_UMLS | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.415 | Obesity_Condition_ICD10 | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.416 | Obesity_Condition_ICD9 | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.365 | Other Revascularization_CPT | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.559 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.560 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.561 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.562 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.387 | Podiatry_Taxonomy | active | 2023-11 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.589 | Polypharmacy_Clinical_Grouping_Condition_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.590 | Polypharmacy_Clinical_Grouping_Condition_ICD9 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.525 | Postpartum_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.526 | Postpartum_HCPCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.527 | Postpartum_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.528 | Postpartum_ICD9CM | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.418 | Pre_Hypertension (Pre_HTN)_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.419 | Pre_Hypertension (Pre_HTN)_ICD9 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.502 | Prediabetes_Clinical Grouping Condition_ICD10 | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.255 | Pregnancy Loss_HD_ICD10 | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.479 | Prostate Cancer Screening_HD_ICD9 | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.482 | Prostate Cancer Screening_HD_Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.484 | Prostate Dysplasia_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.486 | Prostate Dysplasia_Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.487 | Prostectomy_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.488 | Prostectomy_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.490 | Prostectomy_Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.463 | Second Trimester_ICD10 | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.470 | Second Trimester_LOINC | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.477 | Second Trimester_CPT | active | 2024-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.300 | Sigmoidoscopy_CPT | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.302 | Sigmoidoscopy_ICD9 | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.363 | Statin Use_RxNorm | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.581 | Systolic Less than 140_HD_Clinical Grouping Event_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.467 | Third Trimester_ICD10 | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.505 | Third Trimester_CPT | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.596 | Thyroid Cancer_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping | active | 2025-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.274 | Total Cholesterol_CPT | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.275 | Total Cholesterol_Lab_Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.568 | Total and Partial Neph_HD_Clinical Grouping Condition_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.569 | Total and Partial Neph_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.572 | Kid Trans and Hx_HD_Clinical Grouping Condition_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.573 | Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.574 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.575 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.576 | Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9 | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.270 | Triglyceride_Lab_Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.199 | Unknown Glucose_Event_ICD9 | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.200 | Unknown Glucose_Event_ICD10 | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.202 | Unknown Glucose_Event_CPT | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.539 | bwell_Vital_Vital Signs Panel_CPT | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.5 | ADD/ADHD Condition | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping | active | 2023-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 | active | 2023-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.424 | BMI >=30_Event_Clinical Condition Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.393 | BMI >=40_Event_Clinical Condition Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event | active | 2024-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.350 | COVID19 Vaccine_Event Clinical Grouping | active | 2023-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping | active | 2023-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.584 | Diastolic Less than 90_HD_Clinical Grouping Event | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition | active | 2025-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping | active | 2024-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event | active | 2024-02 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.580 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event | active | 2024-08 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping | active | 2023-05 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event | active | 2024-06 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.378 | IVF_Grouping | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping | active | 2025-03 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition | active | 2024-04 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping | active | 2023-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition | active | 2024-09 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping | active | 2023-01 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping | active | 2025-02 |